Form 144 Bicara Therapeutics Inc. For: 23 March
#Form 144 #Bicara Therapeutics #SEC filing #restricted securities #insider trading #biotech #March 23
π Key Takeaways
- Form 144 filed for Bicara Therapeutics Inc. on March 23
- Indicates potential sale of restricted securities by insiders
- Commonly signals planned stock transactions by company affiliates
- Requires filing with the SEC for regulatory compliance
π·οΈ Themes
SEC Filings, Biotechnology
Entity Intersection Graph
No entity connections available yet for this article.